C. Dagostini et al., EFFICACY OF COMBINATION THERAPY WITH AMANTADINE, THYMOSIN ALPHA-1 ANDALPHA BETA INTERFERON IN MICE INFECTED WITH INFLUENZA-A VIRUS/, International journal of immunopharmacology, 18(2), 1996, pp. 95-102
The aim of this study was to examine the effects of the antiviral drug
amantadine (AMN) administered in combination with thymosin alpha 1 (T
alpha 1) and murine alpha/beta interferon (IFN) on mice infected with
influenza A PR8 virus. Combined treatment with AMN and T alpha 1, for
4 days, followed by a single injection of IFN, was initiated 1 h afte
r intranasal viral inoculation. The effectiveness of this new chemoimm
unotherapy protocol was seen in the long-term survival of a high perce
ntage of animals and was statistically significant when compared to tr
eatment with single agents in conjunction with chemotherapy or to chem
otherapy alone. In addition, chemoimmunotherapy treatment reduces the
viral titre in the lungs as well as restoring the immunological parame
ters tested (natural killer cell activity; cytotoxic T-lymphocyte resp
onses; CD4(+)/CD8(+) lymphocyte subsets) with respect to all other gro
ups. These results suggest the potential use of these immunomodulating
agents in combination with an antiviral drug in controlling PR8 influ
enza virus infection. Copyright (C) 1996 International Society for Imm
unopharmacology